The top ten surging US stock ETFs are out! Tech stock ETFs soared by up to 430%, and “ETF benchmark” S&P SPY has absorbed US$50.5 billion

Judging from the US stock ETF growth list, ETFs that bet on cryptocurrencies, technology stocks, and the US property market have performed well.

Futu NewsDec 22, 2023 02:42

4 ‘quality’ ASX shares to buy in scary times: expert

4 ‘quality’ ASX shares to buy in scary times: expert

The Motley FoolJul 8, 2022 02:06

ResMed Inc. Stock Rises Friday, Still Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of ResMed Inc. (RMD) inched 0.87% higher to $261.47 Friday, on what proved to be an all-

Dow Jones NewswiresMar 18, 2022 16:27

ResMed Inc. Stock Outperforms Market Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of ResMed Inc. (RMD) slumped 0.18% to $243.92 Friday, on what proved to be an all-around

DowjonesNews MarketWatchFeb 11, 2022 16:22

ResMed Receives Price Target Boost to $234 From $227 From RBC on 'Positive Implications" From Philips Update; Underperform Kept

10:26 AM EST, 01/13/2022 (MT Newswires) -- ResMed (RMD) received a boost to its price target late Wednesday from RBC Capital Markets as the firm sees the health technology company benefiting from iss

MT NewswiresJan 13, 2022 09:32 · Ratings

ResMed Announces Participation in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference

SAN DIEGO, Dec. 30, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the Goldman Sachs 14th Annual Healthcare CEOs Unscrip

GlobeNewswireDec 30, 2021 08:06

ResMed upgraded at KeyBanc citing current competitive backdrop

KeyBanc has raised its recommendation on ResMed (RMD +3.5%) to Overweight from Sector Weight, expecting a "deeper moat" around its market-leading position in sleep apnea given the current competitive

Seeking AlphaDec 21, 2021 14:46 · Ratings

Insider Sell: Resmed

03:52 PM EST, 12/14/2021 (MT Newswires) -- Brett Sandercock, Chief Financial Officer, on December 10, 2021, sold 2,500 shares in Resmed (RMD) for $662,300. Following the Form 4 filing with the SEC, S

MT NewswiresDec 14, 2021 14:56